6.55
price up icon4.23%   0.28
after-market Handel nachbörslich: 6.64 0.09 +1.37%
loading

Finanzdaten der 89 Bio Inc-Aktie (ETNB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
39.00%
57.28
41.21 39.34 42.13 28.52
Interest Income/Expense
0.35%
0.863
0.866 0.959 0.894 2.075
Operating Income/Loss
39.00%
-57.28
-41.21 -39.34 -42.13 -28.52
Income/Loss From Continuing Operations Before Tax
41.84%
-51.58
-36.37 -34.73 -38.39 -28.84
Income Tax Expense/Benefit
0.097
- - - -
Income/Loss From Continuing Operations After Tax
28.45%
-51.68
-40.23 -34.73 -38.39 -28.84
Net Income/Loss
28.45%
-51.68
-40.23 -34.73 -38.39 -28.84
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,886%
95.85
3.21 76.34 74.13 53.17
Diluted Average Shares
2,886%
95.85
3.21 76.34 74.13 53.17
Basic Earnings Per Share
8.00%
-0.54
-0.50 -0.45 -0.52 -0.54
Diluted Earnings Per Share
8.00%
-0.54
-0.50 -0.45 -0.52 -0.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.27
price up icon 0.92%
$71.24
price up icon 2.53%
$32.19
price up icon 0.11%
$27.35
price up icon 8.52%
$104.68
price up icon 2.82%
biotechnology ONC
$252.77
price up icon 10.52%
Kapitalisierung:     |  Volumen (24h):